The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation Sequencing.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Levaillant Lucie, Bouhours-Nouet Natacha, Illouz Frédéric, Amsellem Jager Jessica, Bachelot Anne, Barat Pascal, Baron Sabine, Bensignor Candace, Brac De La Perriere Aude, Braik Djellas Yasmine, Caillot Morgane, Caldagues Emmanuelle, Campas Marie-Neige, Caquard Marylène, Cartault Audrey, Cheignon Julie, Decrequy Anne, Delemer Brigitte, Dieckmann Katherine, Donzeau Aurélie, Doye Emilie, Fradin Mélanie, Gaudillière Mélanie, Gatelais Frédérique, Gorce Magali, Hazart Isabelle, Houcinat Nada, Houdon Laure, Ister-Salome Marielle, Jozwiak Lucie, Jeannoel Patrick, Labarthe Francois, Lacombe Didier, Lambert Anne-Sophie, Lefevre Christine, Leheup Bruno, Leroy Clara, Maisonneuve Benedicte, Marchand Isis, Marquant Emeline, Muszlak Matthias, Pantalone Letitia, Pochelu Sandra, Quelin Chloé, Radet Catherine, Renoult-Pierre Peggy, Reynaud Rachel, Rouleau Stéphanie, Teinturier Cécile, Thevenon Julien, Turlotte Caroline, Valle Aline, Vierge Melody, Villanueva Carine, Ziegler Alban, Dieu Xavier, Bouzamondo Nathalie, Rodien Patrice, Prunier-Mirebeau Delphine, Coutant Régis
Аннотация
METHODS: Targeted NGS was performed in 103 CH-GIS patients from the French national screening program referred to the Reference Center for Rare Thyroid Diseases of Angers University Hospital. The custom targeted NGS panel contained 48 genes. Cases were classified as solved or probably solved depending on the known inheritance of the gene, the classification of the variants according to the American College of Medical Genetics and Genomics, the familial segregation, and published functional studies. Thyroid-stimulating hormone at CH screening and at diagnosis (TSHsc and TSHdg) and free T4 at diagnosis (FT4dg) were recorded.
RESULTS: NGS identified 95 variants in 10 genes in 73 of the 103 patients, resulting in 25 solved cases and 18 probably solved cases. They were mainly due to mutations in the TG (n = 20) and TPO (n = 15) genes. The molecular yield was, respectively, 73% and 25% if TSHsc was ≥ and < 80 mUI/L, 60% and 30% if TSHdg was ≥ and < 100 mUI/L, and 69% and 29% if FT4dg was ≤ and > 5 pmol/L.
CONCLUSION: NGS in patients with CH-GIS in France found a molecular explanation in 42% of the cases, increasing to 70% when TSHsc was ≥ 80 mUI/L or FT4dg was ≤ 5 pmol/L.